Nifty
Sensex
:
:
12968.95
44149.72
-18.05 (-0.14%)
-110.02 (-0.25%)

Pharmaceuticals & Drugs - Global

Rating :
67/99  (View)

BSE: 543064 | NSE: SUVENPHAR

396.95
28.45 (7.72%)
27-Nov-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  368.50
  •  401.00
  •  365.20
  •  368.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1523778
  •  6048.64
  •  420.00
  •  87.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,024.77
  • 33.67
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,195.98
  • 0.63%
  • 9.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.00%
  • 2.78%
  • 23.57%
  • FII
  • DII
  • Others
  • 4.15%
  • 3.54%
  • 5.96%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
237
273
-13%
238
197
21%
185
251
-26%
179
0
0
Expenses
139
147
-6%
126
95
33%
107
129
-17%
99
0
0
EBITDA
98
125
-22%
112
102
9%
77
122
-37%
80
0
0
EBIDTM
41%
46%
47%
52%
42%
49%
45%
0%
Other Income
0
5
-93%
6
2
135%
5
0
1202%
5
0
0
Interest
3
4
-26%
3
4
-16%
7
2
315%
8
0
0
Depreciation
8
6
35%
7
6
28%
7
6
18%
6
0
0
PBT
88
121
-27%
108
96
13%
68
115
-40%
71
0
0
Tax
23
31
-28%
26
21
25%
15
40
-62%
20
0
0
PAT
65
89
-27%
81
75
9%
53
75
-29%
52
0
0
PATM
28%
33%
34%
38%
29%
30%
29%
0%
EPS
5.13
7.03
-27%
6.38
5.86
9%
4.18
5.88
-29%
4.05
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
-
834
378
Net Sales Growth
-
121%
 
Cost Of Goods Sold
-
225
101
Gross Profit
-
608
276
GP Margin
-
73%
73%
Total Expenditure
-
449
206
Power & Fuel Cost
-
38
18
% Of Sales
-
5%
5%
Employee Cost
-
74
30
% Of Sales
-
9%
8%
Manufacturing Exp.
-
72
35
% Of Sales
-
9%
9%
General & Admin Exp.
-
26
13
% Of Sales
-
3%
3%
Selling & Distn. Exp.
-
13
7
% Of Sales
-
2%
2%
Miscellaneous Exp.
-
1
3
% Of Sales
-
0%
1%
EBITDA
-
385
172
EBITDA Margin
-
46%
45%
Other Income
-
18
1
Interest
-
23
3
Depreciation
-
24
12
PBT
-
356
158
Tax
-
88
49
Tax Rate
-
25%
31%
PAT
-
269
109
PAT before Minority Interest
-
269
109
Minority Interest
-
0
0
PAT Margin
-
32%
29%
PAT Growth
-
146%
 
EPS
-
21.11
8.58

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
845
590
Share Capital
13
0
Total Reserves
832
578
Non-Current Liabilities
128
35
Secured Loans
0
0
Unsecured Loans
91
0
Long Term Provisions
8
6
Current Liabilities
320
191
Trade Payables
71
54
Other Current Liabilities
28
19
Short Term Borrowings
94
83
Short Term Provisions
127
35
Total Liabilities
1,292
816
Net Block
357
271
Gross Block
457
347
Accumulated Depreciation
100
77
Non Current Assets
781
393
Capital Work in Progress
102
111
Non Current Investment
307
0
Long Term Loans & Adv.
15
11
Other Non Current Assets
0
0
Current Assets
511
423
Current Investments
31
7
Inventories
175
157
Sundry Debtors
117
148
Cash & Bank
14
13
Other Current Assets
174
61
Short Term Loans & Adv.
135
37
Net Current Assets
191
232
Total Assets
1,292
816

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
416
50
PBT
405
158
Adjustment
53
14
Changes in Working Capital
45
-88
Cash after chg. in Working capital
502
83
Interest Paid
0
0
Tax Paid
-86
-33
Other Direct Exp. Paid
0
0
Extra & Other Items
0
0
Cash From Investing Activity
-422
-65
Net Fixed Assets
-100
Net Investments
-269
Others
-52
Cash from Financing Activity
6
26
Net Cash Inflow / Outflow
1
11
Opening Cash & Equivalents
11
0
Closing Cash & Equivalent
12
11

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
33
0
ROA
26%
13%
ROE
38%
19%
ROCE
45%
24%
Fixed Asset Turnover
2.07
1.09
Receivable days
58
142
Inventory Days
73
152
Payable days
50
87
Cash Conversion Cycle
81
208
Total Debt/Equity
0.22
0.14
Interest Cover
16
58

Annual Reports:


News Update


No Latest News!

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.